(Q35989921)

11 August 2017

1 reference

title

The association between obesity and the progression of prostate and renal cell carcinoma (English)

1 reference

11 August 2017

0 references

Christopher L Amling

1

1 reference

11 August 2017

language of work or name

1 reference

1 November 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

22

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

478-484

1 reference

Prevalence and Trends in Obesity Among US Adults, 1999-2000

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Trends and correlates of class 3 obesity in the United States from 1990 through 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Prevalence and trends in overweight among US children and adolescents, 1999-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Current estimates of the economic cost of obesity in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

The medical-care cost burden of obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Economist takes aim at "big fat" US lifestyle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Obesity as a risk factor for certain types of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Obesity and Mortality from Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Body mass index and risk of prostate cancer in U.S. health professionals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Diet, obesity, and risk of fatal prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Body mass and prostatic cancer: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Dietary fat intake and risk of prostate cancer: A prospective study of 25,708 Norwegian men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Anthropometry and prostate cancer risk: a prospective study of 22,248 Norwegian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Smoking and obesity in relation to the etiology and disease progression of prostate cancer in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

The role of obesity and diet in urological carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Diabetes mellitus and risk of prostate cancer (United States).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Hepatitis B vaccine and liver problems in U.S. children less than 6 years old, 1993 and 1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Insulin resistance and prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Role of the insulin-like growth factor family in cancer development and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Hormonal predictors of prostate cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Biological action of leptin as an angiogenic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Differential effects of leptin on cancer in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Leptin influences cellular differentiation and progression in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Leptin and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

A case-control study of factors affecting the development of renal cell cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

A case-control study of diet and risk of renal adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Risk factors for renal cell carcinoma: results of a population-based case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Increased risk of renal cell cancer among women using diuretics in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Risk factors for renal-cell carcinoma in a French case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Hypertension, obesity and their medications in relation to renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Obesity, hypertension, and the risk of kidney cancer in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

A prospective study of obesity and cancer risk (Sweden).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Risk factors for renal-cell cancer in Shanghai, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Leptin induces tyrosine phosphorylation of cellular proteins including STAT-1 in human renal adenocarcinoma cells, ACHN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Predictors of sex hormone levels among the elderly: a study in Greece.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt--a major factor in the genesis of morbid obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Cancer risk in men exposed in utero to diethylstilbestrol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Estrogen-induced microsatellite DNA alterations are associated with Syrian hamster kidney tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Early precursors of urogenital cancers in former college men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Renal growth factors: past, present and future.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

A possible mechanism by which dietary fat can alter tumorigenesis: lipid modulation of macrophages function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Evidence for alteration of the vitamin D-endocrine system in obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Vitamin D Deficiency in the Morbidly Obese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Prevention of renal cell carcinoma by active vitamin D3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.004

10.1016/J.UROLONC.2004.10.004

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference